BMS-790052, A FIRST-IN CLASS POTENT HEPATITIS C VIRUS NS5A INHIBITOR, DEMONSTRATES MULTIPLE-DOSE PROOF-OF-CONCEPT IN SUBJECTS WITH CHRONIC GT1 HCV INFECTION
HEPATOLOGY(2010)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined